Both in Pharmaceuticals
Prestige Consumer Healthcare vs Vera Therapeutics
Over the past year PBH returned −19.0% and VERA returned +8.9%; their daily moves had a correlation of 0.02.
PBH −19.0% VERA +8.9%Growth of $1, one year, split-adjusted
| Metric | PBH | VERA |
|---|---|---|
| Price | $49.06 | $30.98 |
| Market cap | $2.32B | $2.23B |
| Today | +0.64% | +1.47% |
| 1 month | +9.6% | 0.0% |
| 6 months | −10.9% | −12.0% |
| Year to date | −20.5% | −38.8% |
| 1 year | −19.2% | +5.5% |
| Revenue growth (YoY) | +6.5% | — |
| Gross margin | 51.3% | — |
| Net margin | 11.0% | — |
| P/E (TTM) | 13.5× | — |
| Price / sales | 2.1× | — |
| Net cash | -$1.95B | $423.9M |
| Dividend yield | — | — |
| Volatility (60d) | 30.7% | 60.3% |
| Short % of float | 8.5% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).